Valuation (64%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 51.49 | 24.69 |
PEG Ratio (TTM) | 17.79 | 3.10 |
P/S Ratio (TTM) | 0.79 | 2.24 |
P/B Ratio (TTM) | 2.26 | 55.87 |
P/FCF Ratio (TTM) | 9.27 | 22.26 |
Price to 5YR AVG Earnings Ratio | 36.12 | 27.14 |
Price to 5YR AVG FCF Ratio | 10.18 | 24.53 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.67% | 14.95% |
ROE (TTM) | 4.47% | 460.70% |
Net Profit Margin (TTM) | 1.50% | 9.16% |
ROIC 5YR AVG | 4.65% | 45.58% |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 1.86% | 77.87% | 43.17% |
Revenue | -1.65% | 1.61% | 1.37% |
Net Income | 2.13% | 79.12% | 41.56% |
Cash Flow | 19.05% | 47.62% | 447.10% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.52 | 1.17 |
Quick Ratio (TTM) | 0.47 | 0.33 |
D/E Ratio (TTM) | 1.15 | 7.83 |
Interest Coverage (TTM) | 10.69 | 10.28 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 2.19 | 5.29 |
LTL to 5YR AVG FCF | 4.05 | 25.23 |
Shares Outstanding Growth 5YR AVG | -3.49% | -2.47% |